Jianqiao Fang Selected Research

Meridians (Jing Luo)

2/2021	The difference in heat transport characteristics of the heart and lung meridians: A comparative study of COPD patients and healthy subjects.
7/2020	Difference in the metabolic characteristics of chronic obstructive pulmonary disease patients and healthy adults.
4/2020	The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant).
9/2018	[Professor FANG Jianqiao's clinical experience in the treatment of primary cervical dystonia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianqiao Fang Research Topics

Disease

44	Pain (Aches) 02/2022 - 02/2015
19	Chronic Pain 09/2022 - 09/2015
11	Neuralgia (Stump Neuralgia) 09/2022 - 02/2016
11	Hyperalgesia 01/2022 - 01/2018
10	Inflammation (Inflammations) 02/2022 - 08/2014
6	Hypersensitivity (Allergy) 01/2020 - 08/2013
5	Stroke (Strokes) 10/2016 - 10/2015
4	Neoplasms (Cancer) 02/2021 - 02/2015
4	Bone Neoplasms (Bone Cancer) 01/2021 - 02/2015
3	Postherpetic Neuralgia 01/2022 - 11/2020
3	Constipation 01/2021 - 06/2014
3	Knee Osteoarthritis 01/2021 - 01/2020
3	Trigeminal Neuralgia (Tic Douloureux) 01/2021 - 02/2019
3	Cognitive Dysfunction 01/2021 - 10/2015
3	Cancer Pain 01/2021 - 05/2017
3	Stable Angina 12/2020 - 04/2020
3	Body Weight (Weight, Body) 12/2020 - 06/2013
3	Ischemia 11/2020 - 01/2019
2	Neuroinflammatory Diseases 01/2022 - 02/2021
2	Reflex Sympathetic Dystrophy (Reflex Sympathetic Dystrophy Syndrome) 01/2022 - 09/2020
2	Peripheral Nervous System Diseases (PNS Diseases) 02/2021 - 11/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 02/2021 - 07/2020
2	Gout 01/2020 - 01/2018
2	Experimental Arthritis 04/2018 - 09/2015
2	Arthritis (Polyarthritis) 04/2018 - 01/2018
1	Allergic Contact Dermatitis 02/2022
1	Contact Dermatitis (Eczema, Contact) 02/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Postoperative Pain 01/2022
1	Carpal Tunnel Syndrome 12/2021
1	Peripheral Nerve Injuries 10/2021
1	Migraine Disorders (Migraine) 07/2021
1	Headache (Headaches) 07/2021
1	Ganglion Cysts (Ganglion) 01/2021
1	Intervertebral Disc Displacement (Herniated Disc) 01/2021
1	Brain Injuries (Brain Injury) 01/2021
1	Tenosynovitis 10/2020

Drug/Important Bio-Agent (IBA)

14	Analgesics (Analgesic Drugs)IBA 10/2021 - 02/2015
7	prostaglandin-inositol cyclic phosphateIBA 01/2022 - 01/2019
5	salicylhydroxamic acid (SHAM)IBA 11/2021 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2019
5	Freund's AdjuvantIBA 01/2021 - 01/2017
4	Opioid Analgesics (Opioids)IBA 09/2021 - 09/2015
3	InflammasomesIBA 01/2022 - 05/2020
3	Therapeutic UsesIBA 02/2021 - 04/2017
3	Opioid Receptors (Opioid Receptor)IBA 01/2018 - 02/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2021 - 11/2019
2	Pharmaceutical PreparationsIBA 02/2021 - 01/2019
2	Nerve Growth Factors (Neurotrophins)IBA 02/2021 - 02/2013
2	Morphine (MS Contin)FDA LinkGeneric 01/2021 - 05/2017
2	Purinergic P2X3 ReceptorsIBA 01/2021 - 12/2020
2	Aminobutyrates (Aminobutyric Acid)IBA 01/2021 - 01/2021
2	Dinoprostone (PGE2)FDA Link 01/2021 - 01/2021
2	trans-crotonin (CTN)IBA 01/2021 - 04/2020
2	Nitroglycerin (Dynamite)FDA LinkGeneric 12/2020 - 12/2015
2	Purinergic Receptors (Receptors, Purine)IBA 12/2020 - 07/2019
2	Insulin (Novolin)FDA Link 01/2020 - 06/2013
2	Interleukin-33IBA 01/2020 - 11/2016
2	Capsaicin (Zostrix)FDA Link 01/2020 - 11/2019
2	Neutralizing AntibodiesIBA 01/2019 - 11/2016
2	Collagen Type II (Type II Collagen)IBA 04/2018 - 09/2015
2	BuffersIBA 05/2017 - 02/2015
2	Phosphates (Orthophosphate)IBA 05/2017 - 02/2015
2	Messenger RNA (mRNA)IBA 02/2015 - 02/2013
1	Dopamine Receptors (Dopamine Receptor)IBA 09/2022
1	AllergensIBA 02/2022
1	AntioxidantsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	LigandsIBA 01/2022
1	OpsinsIBA 01/2022
1	OrexinsIBA 01/2022
1	Ibuprofen (Motrin)FDA LinkGeneric 07/2021
1	Ion Channels (Ion Channel)IBA 03/2021
1	prucaloprideIBA 01/2021
1	CarrageenanIBA 01/2021
1	Insulin-Like PeptidesIBA 01/2021
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2021
1	Protein Kinase C-epsilonIBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021
1	ParvalbuminsIBA 01/2021
1	A-317491IBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 12/2020
1	Blood Glucose (Blood Sugar)IBA 12/2020
1	Metabotropic Glutamate 5 ReceptorIBA 01/2020

Therapy/Procedure

41	Electroacupuncture 09/2022 - 02/2013
15	Therapeutics 01/2022 - 08/2013
10	Acupuncture Therapy 12/2021 - 10/2015
5	Acupuncture Points (Acupuncture Point) 02/2021 - 02/2013
4	Analgesia 09/2022 - 12/2015
4	Meridians (Jing Luo) 02/2021 - 09/2018
3	Drug Therapy (Chemotherapy) 02/2021 - 01/2019
3	Moxibustion 01/2020 - 10/2014
3	Transcutaneous Electric Nerve Stimulation (TENS) 01/2019 - 01/2014
2	Anesthesia 01/2022 - 01/2020
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2022
1	Injections 01/2021
1	Spinal Injections 01/2021
1	Conservative Treatment 10/2020